tiprankstipranks
Simulations Plus (SLP)
NASDAQ:SLP
US Market
Want to see SLP full AI Analyst Report?

Simulations Plus (SLP) Blogger Opinions & Sentiment

556 Followers

Blogger Sentiment

Bearish: 60.00%
Sector Average
Neutral
SLP Blogger sentiment is based on 5 Blogger Opinions. The Blogger sentiment is more Bearish than other stocks in the Healthcare sector.

Blogger Article Distribution

ArticleDistribution
100% SeekingAlpha
The distribution of articles among the main online Financial Blogging platforms.

Top Blogger Bearish Predictions

Simulations Plus: Down Substantially, Not An Automatic Buy
SeekingAlpha
Simulations Plus: Further Downside Is Likely (Rating Downgrade)
SeekingAlpha
Recent negative articles by top bloggers.

Top Blogger Bullish Predictions

Simulations Plus: Buying On Long-Term Silico Drug-Development
SeekingAlpha
The Bottom Fishing Club - Simulations Plus: Huge Potential In AI Drug Discovery
SeekingAlpha
Recent positive articles by top bloggers.

Financial Blogger Predictions​​

Blogger Performance
Any
Any
Blogger Sentiment
Any
Any

FAQ

What do Seeking Alpha bloggers think of SLP?
Seeking Alpha’s Grassroots Trading has a Neutral Sentiment.
    What do Motley Fool contributors think of SLP?
    Currently there's no blogger sentiment for SLP.
    What Is SLP’s Blogger Sentiment?
    SLP’s Blogger Sentiment is Neutral.
      What was the most recent blogger prediction for SLP?
      The most recent blogger prediction for SLP was made by Grassroots Trading, who was Neutral on the stock.
        How can I follow the stock ratings of top Top Financial Bloggers?
        Head over to our Expert Center to see a list of the Top 100 Financial Bloggers and follow the financial bloggers of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Stocks with the Highest Top Blogger Ratings in the Healthcare sector
          PRRUFImmutep Ltd
          PRNAFAlterity Therapeutics
          PBIGFParadigm Biopharmaceuticals
          NURPFNeuren Pharmaceuticals Limited
          MEOBFMesoblast Limited